MedPath

Periodontal Therapy on the Gut Microbiome of Inflammatory Bowel Disease

Not Applicable
Recruiting
Conditions
Dysbiosis
Periodontal Diseases
IBD
Inflammation
Interventions
Procedure: Full mouth scaling and root planing (FMSRP)
Registration Number
NCT04790825
Lead Sponsor
University of Turin, Italy
Brief Summary

Periodontitis and inflammatory bowel disease have been associated by meta-epidemiologic evidence, although their mechanistic connection needs to be further explored. Oral-gut axis is implicated in the pathogenesis of several chronic inflammatory conditions, but to date no studies have evaluated the impact of periodontal treatment on gut ecology. Thus, the present randomised clinical trial is aimed at investigating the effect of intensive or conventional periodontal therapy on the gut microbiome and parameters of systemic inflammation of patients diagnosed with inflammatory bowel disease.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
40
Inclusion Criteria
  • clinical and instrumental diagnosis of ulcerative colitis or Crohn's disease
  • periodontitis Stage III or IV
  • BMI between 20 and 29 kg/m2
  • free diet
  • presence of at least 20 teeth
Exclusion Criteria
  • Systemic diseases (including diabetes, thyroid, liver, or kidney diseases)
  • dietary allergies
  • use of antibiotics or probiotics during the previous 30 days
  • pregnancy or breast feeding

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Community-based periodontal careFull mouth scaling and root planing (FMSRP)Standard cycle of supragingival mechanical scaling and polishing.
Intensive periodontal treatmentFull mouth scaling and root planing (FMSRP)Adjunctive full-mouth intensive removal of subgingival dental plaque biofilms with the use of scaling and root planing after the administration of local anesthesia.
Primary Outcome Measures
NameTimeMethod
Changes in microbiome alpha diversity measured from stool samples at 3 monthsBaseline and 90 days

Taxonomic and functional variation of gut bacteria after treatment

Secondary Outcome Measures
NameTimeMethod
Changes in periodontal pocket depth (PPD) at 3 monthsBaseline and 90 days

Variation in PPD after therapy assessed using a millimetre marked manual periodontal probe at 6 sites per tooth element

Changes in microbiome alpha diversity measured from saliva samples at 3 monthsBaseline and 90 days

Taxonomic and functional variation of salivary bacteria after treatment

Change of the inflammatory markers levels in plasmaBaseline and 90 days

Concentration of cytokines and biomarkers in plasma samples

Changes in mean clinical attachment level (CAL) at 3 monthsBaseline and 90 days

Variation in CAL after therapy assessed using a millimetre marked manual periodontal probe at 6 sites per tooth element

Changes in full mouth bleeding score (FMBS) at 3 monthsBaseline and 90 days

Variation in the percentage of bleeding sites after therapy assessed by gentle probing at 6 sites per tooth element

Trial Locations

Locations (1)

CIR Dental School

🇮🇹

Turin, Italy

© Copyright 2025. All Rights Reserved by MedPath